Greenwood Capital Associates’s CVS Health CVS Stock Holding History

Greenwood Capital Associates’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Sell	10,544 -9,235	-47%	-$824K	0.11%	155
2026 Q1	$1.42M	Buy	19,779 +71	+0.4%	+$5.47K	0.16%	127
2025 Q4	$1.56M	Buy	19,708 +834	+4%	+$65.7K	0.17%	118
2025 Q3	$1.42M	Sell	18,874 -61	-0.3%	-$4.18K	0.16%	118
2025 Q2	$1.31M	Buy	+18,935	New	+$1.24M	0.16%	118
2023 Q1	–	Sell	-49,363	Closed	-$4.6M	–	239
2022 Q4	$4.6M	Buy	49,363 +20,836	+73%	+$2.01M	0.75%	48
2022 Q3	$2.72M	Buy	28,527 +26,147	+1,099%	+$2.59M	0.47%	59
2022 Q2	$220K	Buy	2,380 +1,890	+386%	+$184K	0.04%	201
2022 Q1	$50K	Sell	490 -2,321	-83%	-$244K	0.01%	174
2021 Q4	$290K	Buy	+2,811	New	+$260K	0.04%	203
2019 Q1	–	Sell	-118,307	Closed	-$7.75M	–	182
2018 Q4	$7.75M	Buy	118,307 +61,480	+108%	+$4.59M	2.03%	10
2018 Q3	$4.47M	Buy	+56,827	New	+$4.06M	0.97%	41
2018 Q1	–	Sell	-25,972	Closed	-$1.88M	–	199
2017 Q4	$1.88M	Buy	+25,972	New	+$1.89M	0.44%	81

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Greenwood Capital Associates's CVS Position: Q2 2026 in Review

Greenwood Capital Associates reduced its CVS Health (CVS) stake by 47% in Q2 2026, selling an estimated $824K and leaving 10,544 shares worth $1.09M. The position accounts for 0.11% of the portfolio, ranked #155.

Greenwood Capital Associates first reported a position in CVS in Q4 2017 and has held it in 13 quarters since. The position peaked at $7.75M in Q4 2018. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Greenwood Capital Associates held 10,544 shares of CVS Health worth $1.09M as of Q2 2026.
Greenwood Capital Associates sold 9,235 CVS Health shares in Q2 2026, an estimated $824K.
CVS Health made up 0.11% of Greenwood Capital Associates's portfolio in Q2 2026, its #155 holding.
Greenwood Capital Associates first reported a position in CVS Health in Q4 2017 and has held it in 13 quarters since.
Greenwood Capital Associates's CVS Health position peaked at $7.75M in Q4 2018.
2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Greenwood Capital Associates's 13F filing for Q2 2026, filed 28 Jul 2026.